1. Home
  2. ATNF vs CPHI Comparison

ATNF vs CPHI Comparison

Compare ATNF & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNF
  • CPHI
  • Stock Information
  • Founded
  • ATNF 2016
  • CPHI N/A
  • Country
  • ATNF United States
  • CPHI China
  • Employees
  • ATNF N/A
  • CPHI N/A
  • Industry
  • ATNF Biotechnology: Pharmaceutical Preparations
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATNF Health Care
  • CPHI Health Care
  • Exchange
  • ATNF Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • ATNF 4.1M
  • CPHI 4.0M
  • IPO Year
  • ATNF N/A
  • CPHI N/A
  • Fundamental
  • Price
  • ATNF $1.25
  • CPHI $0.21
  • Analyst Decision
  • ATNF
  • CPHI
  • Analyst Count
  • ATNF 0
  • CPHI 0
  • Target Price
  • ATNF N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • ATNF 84.0K
  • CPHI 701.9K
  • Earning Date
  • ATNF 03-04-2025
  • CPHI 03-31-2025
  • Dividend Yield
  • ATNF N/A
  • CPHI N/A
  • EPS Growth
  • ATNF N/A
  • CPHI N/A
  • EPS
  • ATNF N/A
  • CPHI N/A
  • Revenue
  • ATNF N/A
  • CPHI $5,544,620.00
  • Revenue This Year
  • ATNF N/A
  • CPHI N/A
  • Revenue Next Year
  • ATNF $54.15
  • CPHI N/A
  • P/E Ratio
  • ATNF N/A
  • CPHI N/A
  • Revenue Growth
  • ATNF N/A
  • CPHI N/A
  • 52 Week Low
  • ATNF $1.16
  • CPHI $0.13
  • 52 Week High
  • ATNF $17.75
  • CPHI $0.50
  • Technical
  • Relative Strength Index (RSI)
  • ATNF 33.17
  • CPHI 48.21
  • Support Level
  • ATNF $1.31
  • CPHI $0.19
  • Resistance Level
  • ATNF $1.38
  • CPHI $0.24
  • Average True Range (ATR)
  • ATNF 0.06
  • CPHI 0.02
  • MACD
  • ATNF 0.01
  • CPHI 0.00
  • Stochastic Oscillator
  • ATNF 0.00
  • CPHI 46.67

About ATNF 180 Life Sciences Corp.

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: